Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

In vivo depletion of CD4+FOXP3+ Treg cells by the PC61 anti-CD25 monoclonal antibody is mediated by FcgammaRIII+ phagocytes.

Setiady YY, Coccia JA, Park PU.

Eur J Immunol. 2010 Mar;40(3):780-6. doi: 10.1002/eji.200939613.

2.
3.

Anti-CD25 mAb administration prevents spontaneous liver transplant tolerance.

Li W, Carper K, Liang Y, Zheng XX, Kuhr CS, Reyes JD, Perkins DL, Thomson AW, Perkins JD.

Transplant Proc. 2006 Dec;38(10):3207-8.

PMID:
17175224
4.

CD25+ regulatory T cell inhibition enhances vaccine-induced immunity to neuroblastoma.

Johnson BD, Jing W, Orentas RJ.

J Immunother. 2007 Feb-Mar;30(2):203-14.

PMID:
17471167
5.

Regulatory T cells are necessary for implantation and maintenance of early pregnancy but not late pregnancy in allogeneic mice.

Shima T, Sasaki Y, Itoh M, Nakashima A, Ishii N, Sugamura K, Saito S.

J Reprod Immunol. 2010 Jun;85(2):121-9. doi: 10.1016/j.jri.2010.02.006. Epub 2010 May 2.

PMID:
20439117
6.

Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.

He F, Chen Z, Xu S, Cai M, Wu M, Li H, Chen X.

Surgery. 2009 Jun;145(6):663-74. doi: 10.1016/j.surg.2009.01.016. Epub 2009 Apr 19.

PMID:
19486771
7.

Distinct responses of two hepatocellular carcinoma cell lines of a similar origin to immunotherapies targeting regulatory or effector T cells.

Nagayama Y, Hase W, Motoyoshi Y, Saitoh O, Sogawa R, Nakao K.

Oncol Rep. 2007 May;17(5):1269-73.

PMID:
17390075
8.

Targeting acute allograft rejection by immunotherapy with ex vivo-expanded natural CD4+ CD25+ regulatory T cells.

Xia G, He J, Zhang Z, Leventhal JR.

Transplantation. 2006 Dec 27;82(12):1749-55.

PMID:
17198271
9.

The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice.

Qu Y, Zhang B, Zhao L, Liu G, Ma H, Rao E, Zeng C, Zhao Y.

Transpl Immunol. 2007 Apr;17(3):153-61. Epub 2007 Jan 24.

PMID:
17331841
11.

Short-term anti-CD25 monoclonal antibody treatment and neogenetic CD4(+)CD25(high) regulatory T cells in kidney transplantation.

Wang Z, Xiao L, Shi BY, Qian YY, Bai HW, Chang JY, Cai M.

Transpl Immunol. 2008 Apr;19(1):69-73. doi: 10.1016/j.trim.2008.01.005. Epub 2008 Feb 22.

PMID:
18346640
12.

Incomplete depletion and rapid regeneration of Foxp3+ regulatory T cells following anti-CD25 treatment in malaria-infected mice.

Couper KN, Blount DG, de Souza JB, Suffia I, Belkaid Y, Riley EM.

J Immunol. 2007 Apr 1;178(7):4136-46.

13.

Multiple antitumor mechanisms downstream of prophylactic regulatory T-cell depletion.

Teng MW, Swann JB, von Scheidt B, Sharkey J, Zerafa N, McLaughlin N, Yamaguchi T, Sakaguchi S, Darcy PK, Smyth MJ.

Cancer Res. 2010 Apr 1;70(7):2665-74. doi: 10.1158/0008-5472.CAN-09-1574. Epub 2010 Mar 23.

14.

Peripheral T-cell tolerance associated with prostate cancer is independent from CD4+CD25+ regulatory T cells.

Degl'Innocenti E, Grioni M, Capuano G, Jachetti E, Freschi M, Bertilaccio MT, Hess-Michelini R, Doglioni C, Bellone M.

Cancer Res. 2008 Jan 1;68(1):292-300. doi: 10.1158/0008-5472.CAN-07-2429.

15.

Depletion of CD4+CD25+ regulatory T cells enhances interleukin-2-induced antitumor immunity in a mouse model of colon adenocarcinoma.

Imai H, Saio M, Nonaka K, Suwa T, Umemura N, Ouyang GF, Nakagawa J, Tomita H, Osada S, Sugiyama Y, Adachi Y, Takami T.

Cancer Sci. 2007 Mar;98(3):416-23.

16.

Inactivation of CD4+ CD25+ regulatory T cells during early mycobacterial infection increases cytokine production but does not affect pathogen load.

Quinn KM, McHugh RS, Rich FJ, Goldsack LM, de Lisle GW, Buddle BM, Delahunt B, Kirman JR.

Immunol Cell Biol. 2006 Oct;84(5):467-74. Epub 2006 Jul 20.

PMID:
16869940
17.

Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low-affinity activating Fcgamma receptors.

Stavenhagen JB, Gorlatov S, Tuaillon N, Rankin CT, Li H, Burke S, Huang L, Vijh S, Johnson S, Bonvini E, Koenig S.

Cancer Res. 2007 Sep 15;67(18):8882-90. Erratum in: Cancer Res. 2008 Sep 15;68(18):7692. Vijh, Sujata [added].

18.

Depletion of CD4+ CD25+ regulatory cells augments the generation of specific immune T cells in tumor-draining lymph nodes.

Tanaka H, Tanaka J, Kjaergaard J, Shu S.

J Immunother. 2002 May-Jun;25(3):207-17.

PMID:
12000862
19.

Presence of functional mouse regulatory CD4+CD25+T cells in xenogeneic neonatal porcine thymus-grafted athymic mice.

Sun Z, Zhao L, Wang H, Sun L, Yi H, Zhao Y.

Am J Transplant. 2006 Dec;6(12):2841-50.

20.

The significantly enhanced frequency of functional CD4+CD25+Foxp3+ T regulatory cells in therapeutic dose aspirin-treated mice.

Javeed A, Zhang B, Qu Y, Zhang A, Sun C, Zhang L, Liu J, Zeng C, Zhao Y.

Transpl Immunol. 2009 Mar;20(4):253-60. doi: 10.1016/j.trim.2008.12.001. Epub 2009 Jan 13.

PMID:
19146957

Supplemental Content

Support Center